Skip to content
Research Article Open access CC BY 4.0

Lifitegrast Ophthalmic Solution – A Review

S. Padmaja, K. Lakshitha Niyatee Rao

Journal of Pharmaceutical Research International · pp. 186–188 · Published 14 Dec 2021

10.9734/jpri/2021/v33i57A33984

Abstract

Introduction: In this review article the safety and efficacy of of Lifitegrast™ in the management of dry eye disease is described. Methods: Search was carried out using related search terms in data bases like pubmed and related articles were referred. Result: A larger reduction in Eye dryness Score (EDS) was seen with Lifitegrast™. Conclusion: Lifitegrast™ ophthalmic solution 5% provides a new option for the treatment of dry eyes.

Lifitegrast™ eye dryness drug complication

References (3)

  1. 1 Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease [DOI]
  2. 2 Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease [DOI]
  3. 3 Embryotoxicity and Toxicokinetics of the Antimalarial Artesunate in Rats [DOI]

Cited by 1

Multidimensional immunotherapy for dry eye disease: current status and future directions

Duliurui Huang, Zhijie Li · Frontiers in Ophthalmology · 2024

Article metrics

Real usage data collected on this platform.

6

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.